AeroRx Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch AeroRx Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD (NCT06841640) | AeroRx Therapeutics Inc. | 2025-01-15 |
Track AeroRx Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.